| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |